Clinical trials have long been plagued by inefficiency, lack of
diversity and the inability to leverage data. The pandemic increased the
need to modernize trials, which pushed many trials to lean on technology
to conduct trials remotely. Ben Leonard explains why money is pouring
into the space and why many clinical trials are still stuck in the
previous century.